Wire Stories
Personalis Announces Collaboration with MapKure to Use Personalis� NeXT Platform� for Clinical Trials and Companion Diagnostic Development
MENLO PARK, Calif.–(BUSINESS WIRE)–#immunooncology–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced a collaboration with MapKure, LLC, a...